The current state of bioprocessing is transformational and transitional – and the data and strategies are matching that.
So for 2017, Cell Culture World Congress USA is focusing on using analysis of metabolic dynamics as a systems biology approach to CHO cell enhancement, bridging the gap between upstream and downstream manufacturing, and how we can enhance (and replace!) CHO cells in a bioreactor environment to maximize productivity
The event is co-located with Americas Antibody Congress and the World Biosimilar Congress USA, so that even if you want a break from bioprocessing and want to discuss engineering or pricing, you have some place to go – and your ticket includes admission to all three.